November #149 : Ritonavir News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Free At Last?

It's a Girl!




Condomless Sex? Maybe Not Yet

Meditation Matters

Boys and Girls Together

Med Alert-November 2008

From the Inside: Strength to Spare

Ritonavir News

A Liver-Cleansing Herb’s Benefits Begin to Bloom

Sweet Spot

Bottoms Up

Starting Out Late?

Eat Well, Pay Little

Is Organic Food Worth the Splurge?

Coats of Many Colors




Prison Break

Ladies First

POS/NEG

Shout Out!

In Their Words

You Said It...

Life’s Rich Pageant

How to... Disclose in the Heat of the Moment




Editor's Letter-November 2008

Your Feedback-November 2008



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

November 2008


Ritonavir News

Most protease inhibitor (PI)-based HIV combos are boosted with the PI Norvir (ritonavir). Norvir slows the breakdown of other PIs, keeping them around longer to do their work. But it can also raise some blood-fat levels and produce gastric distress. Two developments may offer future options:

New Booster:
Gilead Sciences is testing a new compound that could replace Norvir if it makes it beyond early trials.


New Norvir: Abbott Pharmaceuticals, maker of Norvir, is producing a reformulated tablet version of the PI, currently available only as a gel cap. The tablet won’t need refrigeration and may be easier on the stomach—and could appear next year. In 2005, a tablet form of Kaletra (lopinavir boosted by ritonavir) replaced the old version.

Editor's Note: An error in the previous version of this story has been corrected.



Search: Norvir, medication, protease inhibitor


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.